NCT03066544 - Status Migrainosus - Differentiating Between Responders and Non-responders | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions

Migraine

Interventions

DRUG

Bupivacaine

Nerve blocks with bupivacaine will be performed at initial visit

DRUG

Naratriptan Pill

one pill will be administered twice each day for 5 days

DRUG

Dexamethasone

one tablet will be administered twice each day for 3 days

DRUG

Ketorolac

ketorolac will be administered intramuscularly (IM) or intravenously (IV) at initial visit

Trial Locations (1)

RECRUITING

Hartford HealthCare Headache Center, Wethersfield